Peter Merkel

66PUBLICATIONS
240CO-AUTHORS
Respiratory diseasesMedical microbiology not elsewhere classifiedSystems physiologyCharacterisation of biological macromoleculesPacific Peoples medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Nov 05, 2025
Clinician views concerning the prevalence and impact of granulomas on the diagnosis, management, and outcomes of ANCA-associated vasculitis.

Mats Junek, Lynn A Fussner, Arielle Mendel

|Sep 22, 2025
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis.

Parameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin

|Aug 31, 2025
Discontinuation of Oral Glucocorticoids and Achievement of Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis Treated With Benralizumab or Mepolizumab.

Michael E Wechsler, Nancy Agmon-Levin, David R W Jayne

|Jul 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis.

Hana Sabanovic, John D Pauling, Murray Baron

|Apr 07, 2025
Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Combined Data From Three Clinical Trials.

Peter A Merkel, Michael D George, Huibin Yue

|Mar 04, 2025
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.

Duvuru Geetha, Christian Pagnoux, Sebastian E Sattui

Pageof 11

Frequent Collaborators

23 joint publications

Peter C Grayson

13 joint publications

David R W Jayne

13 joint publications

Joanna C Robson

13 joint publications

Richard A Watts